In a recent decision involving the Biologics Price Competition and Innovation Act ("BPCIA") (Genentech, Inc. and City of Hope v. Amgen Inc.) the Delaware District Court dismissed a claim seeking to enforce a statement of...more
5/14/2018
/ Amgen ,
Biosimilars ,
BPCIA ,
Failure To State A Claim ,
Genentech ,
Motion to Dismiss ,
Patent Dance ,
Patent Litigation ,
Patents ,
Private Right of Action ,
Subject Matter Jurisdiction